These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2251197)

  • 21. Anaphylactic reaction following i.v. administration of 5-fluorouracil.
    Millá Santos A; Sanchiz Medina F
    Cancer Treat Rep; 1986 Nov; 70(11):1346. PubMed ID: 3768880
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
    Chang YC; Falkson G; Tormey DC; Crowley J
    Cancer Clin Trials; 1981; 4(4):377-80. PubMed ID: 6797746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pigmentary effects from the protracted infusion of 5-fluorouracil.
    Perlin E; Ahlgren JD
    Int J Dermatol; 1991 Jan; 30(1):43-4. PubMed ID: 1993564
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of regimens for the simultaneous and sequential administration of cytostatics in the combined chemotherapy of disseminated forms of breast cancer].
    Korman DB; Borisov AI; Maslova IA; Pines EV
    Vopr Onkol; 1985; 31(5):21-6. PubMed ID: 3925630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in advanced breast carcinoma.
    Dalley DN; Levi JA; Aroney RS
    Med J Aust; 1980 Mar; 1(5):216-8. PubMed ID: 6990214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of adjuvant chemotherapy in breast carcinoma with a combination of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and AC (doxorubicin, cyclophosphamide). Initial results of a national cooperative study].
    Pribylová O; Petruzelka L; Honová H; Fischer J; Bustová I; Siffnerová H; Kůta M; Miller V; Hacklová M; Machácek J; Kohoutek M; Vodvárka P; Kyselá T; Tajblová J; Suk J; Dorazilová V; Bauer J
    Sb Lek; 1998; 99(1):25-31. PubMed ID: 9748796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weekly paclitaxel and 5-fluorouracil in pretreated patients with metastatic breast cancer: a phase I study.
    Cortesi E; Grifalchi F; Ramponi S; Padovani A; Mancuso A; Paoluzzi L; Ferrau F; Oliva A
    Anticancer Res; 2003; 23(2C):1961-6. PubMed ID: 12820487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
    Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
    Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-line chemotherapy with fluorouracil-epirubicin-navelbine (FEN) combination in advanced breast cancer.
    Ardavanis A; Tryfonopoulos D; Orphanos G; Ioannidis G; Karamouzis M; Rigatos G
    Anticancer Res; 2005; 25(6C):4493-8. PubMed ID: 16334132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Side effects of combined antineoplastic chemotherapy on hemostasis in patients with breast cancer].
    Pinto Pedrazzi AH; de Souza AM
    Rev Fac Farm Odontol Ribeiro Preto; 1982; 19(1):29-41. PubMed ID: 6964932
    [No Abstract]   [Full Text] [Related]  

  • 32. Muehrcke's lines on nails after cyclophosphamide/adriamycin/fluorouracil.
    Gül U; Kiliç A
    Ann Pharmacother; 2004 Jun; 38(6):1089-90. PubMed ID: 15122002
    [No Abstract]   [Full Text] [Related]  

  • 33. [The combination of thio-tepa and 5 fluorouracil as a palliative therapy for breast cancer].
    Chauvergne J; Hoerni B; Hoerni-Simon G; Durand M
    Rev Fr Gynecol Obstet; 1973 Mar; 68(3):159-65. PubMed ID: 17472211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fluorouracil for advanced breast cancer].
    Solheim OP
    Tidsskr Nor Laegeforen; 1974 Jan; 94(2):69-71. PubMed ID: 4822268
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
    Tisman G; Wu SJ
    Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
    Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
    In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed bleomycin-induced hyperpigmentation and pressure on the skin.
    vonHilsheimer GE; Norton SA
    J Am Acad Dermatol; 2002 Apr; 46(4):642-3. PubMed ID: 11907529
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhanced hyperpigmentation with combination chemotherapy.
    Knobf MT; Kalm D
    Oncol Nurs Forum; 1990; 17(5):762. PubMed ID: 2251197
    [No Abstract]   [Full Text] [Related]  

  • 39. Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.
    Chen GY; Lee JY; Chen WC
    Br J Dermatol; 2005 Jun; 152(6):1383-5. PubMed ID: 15949026
    [No Abstract]   [Full Text] [Related]  

  • 40. Serpentine supravenous pigmentation. A rare vasculo-cutaneous effect induced by systemic 5-fluorouracil.
    Rao R; Balachandran C
    Indian J Dermatol Venereol Leprol; 2010; 76(6):714-5. PubMed ID: 21079327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.